Researchers Investigate Repurposed Drugs with Existing Real-World Data
November 14, 2022
A review that was published recently explored the use of real-world data (RWD) in repurposing existing drugs for new indications. Drug repurposing allows for more rapid market access, and is increasingly being prioritized by regulatory bodies in Australia and elsewhere. RWD can help identify and develop repurposed drugs.
According to first author George Tan, “Real-world clinical data has great potential to identify new medications that could be repurposed. This includes data routinely collected when you see your doctor, get a prescription filled at your local pharmacy, or get admitted to hospital. After reviewing a total of 250 articles worldwide, we found studies on data mining for novel drug repurposing ideas and studies to confirm existing repurposing hypotheses. These studies applied different methodologies, from traditional cohort study designs to cutting-edge data-mining techniques”
To read more, click here.
(Source: Mirage News, November 14th, 2022)